Abstract
Preeclampsia is a common complication during pregnancy that significantly affects maternal and fetal health. In recent years, aspirin has garnered widespread attention as a crucial medication for the prevention of preeclampsia. This review examines the effects of aspirin administration at various gestational weeks on the risk of developing preeclampsia, analyzing relevant research findings and theoretical underpinnings. Additionally, the review discusses the optimal timing and dosage of aspirin use in this context. Through a comprehensive analysis of existing literature, this article aims to provide guidance for clinical practice in the prevention of preeclampsia.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
